|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500096014 |
|
最近更新日期: Date of Last Refreshed on: |
2025-01-16 10:03:38 |
|
注册时间: Date of Registration: |
2025-01-16 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
小儿烟雾病术后神经功能恶化的危险因素分析 |
|
Public title: |
Risk Factors for Neurologic Deterioration After Revascularization Surgery in Children with Moyamoya Disease |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
小儿烟雾病术后神经功能恶化的危险因素分析 |
|
Scientific title: |
Risk Factors for Neurologic Deterioration After Revascularization Surgery in Children with Moyamoya Disease |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张娜 |
研究负责人: |
徐颖怡 |
|
Applicant: |
Na Zhang |
Study leader: |
Yingyi Xu |
|
申请注册联系人电话: Applicant telephone: |
+86 135 6040 9867 |
研究负责人电话:
Study leader's |
+86 136 3232 4394 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
na999666@163.com |
研究负责人电子邮件: Study leader's E-mail: |
xuyingyi@gzhmu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国广东省广州市人民中路318号 |
研究负责人通讯地址: |
中国广东省广州市人民中路318号 |
|
Applicant address: |
318 Middle Renmin Road, Guagnzhou, Guangdong, China |
Study leader's address: |
318 Middle Renmin Road, Guagnzhou, Guangdong, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
广州医科大学附属妇女儿童医疗中心 |
||
|
Applicant's institution: |
Women and Children's Medical Center Affiliated to Guangzhou Medical University |
||
|
研究负责人所在单位: |
广州医科大学附属妇女儿童医疗中心 |
||
|
Affiliation of the Leader: |
Women and Children's Medical Center Affiliated to Guangzhou Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
穗妇儿科伦批字[2024]第461A01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
广州市妇女儿童医疗中心科学研究伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Guangzhou Women and Children's Medical Centre |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-11-22 00:00:00 | ||
|
伦理委员会联系人: |
龙燕 |
||
|
Contact Name of the ethic committee: |
Long Yan |
||
|
伦理委员会联系地址: |
中国广东省广州市金穗路9号 |
||
|
Contact Address of the ethic committee: |
9 Jinsui Road, Tianhe District, Guangzhou, Guangdong, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 20 3836 7270 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
广州医科大学附属妇女儿童医疗中心 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
Women and Children's Medical Center Affiliated to Guangzhou Medical University |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国广东省广州市人民中路318号 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
318 Middle Renmin Road, Guagnzhou, Guangdong, China |
||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
广东省科技厅项目 |
||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
Guangdong Science and Technology Department project |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病: |
烟雾病 |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
Moyamoya Disease |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
回顾性研究 | ||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
Retrospective study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
评估接受烟雾病血运重建手术的儿童中可改变的神经功能恶化危险因素,为改善此类患儿的麻醉管理提供临床依据。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
Evaluate the modifiable risk factors for neurological deterioration in children undergoing revascularization surgery for Moyamoya disease, and provide clinical evidence for improving anesthesia management in such children. |
||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
2015年1月至2024年10月在广州医科大学附属妇女儿童医疗中心和三九脑科医院接受血管重建手术的烟雾病患儿。纳入标准:1.患者年龄小于18岁;2.诊断结果符合烟雾病分类;3.病历完整。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
Children with Moyamoya disease who underwent vascular reconstruction surgery at Guangzhou Medical University Affiliated Women and Children's Medical Center and Sanjiu Brain Hospital from January 2015 to October 2024. Inclusion criteria: 1.Patients under the age of 18; 2. The diagnosis result conforms to the classification of smoke disease; 3.Complete medical records. |
||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
1.患者有严重并发症及凝血功能障碍; 2.术后7天内死亡。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
1. Patients with severe complications and coagulation dysfunction; 2. Death within 7 days after surgery. |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-01-16 00:00:00至 To 2025-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-01-17 00:00:00 至 To 2025-01-24 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
N/A |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
原始数据在试验完成后6个月内公开,采用临床试验公共平台管理和公布, http://www.medresman.org.cn。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Original data will be shared 6 month after the trial complete on the clinical trial public platform, http://www.medresman.org.cn. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
所有课题数据都将用redcap收集并由课题负责人上锁密封保存,不会泄露患者任何私人信息。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
All the data of the study will be collected by redcap system and locked and sealed by the person in charge of the study, without revealing any personal information of the patients. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |